PMID- 33994067 OWN - NLM STAT- MEDLINE DCOM- 20220105 LR - 20220802 IS - 1424-3911 (Electronic) IS - 1424-3903 (Print) IS - 1424-3903 (Linking) VI - 21 IP - 5 DP - 2021 Aug TI - Acute pancreatitis-induced islet dysfunction in ferrets. PG - 839-847 LID - S1424-3903(21)00147-2 [pii] LID - 10.1016/j.pan.2021.04.008 [doi] AB - BACKGROUND: /Objectives: The pathogenesis of hyperglycemia during acute pancreatitis (AP) remains unknown due to inaccessibility of human tissues and lack of animal models. We aimed to develop an animal model to study the mechanisms of hyperglycemia and impaired glucose tolerance in AP. METHODS: We injected ferrets with intraperitoneal cerulein (50 mug/kg, 9 hourly injections) or saline. Blood samples were collected for glucose (0, 4, 8, 12, 24h); TNF-alpha, IL-6 (6h); amylase, lipase, insulin, glucagon, pancreatic polypeptide (PP), glucagon-like peptide-1 (GLP-1), and gastric inhibitory polypeptide (GIP) (24h). Animals underwent oral glucose tolerance test (OGTT), mixed meal tolerance test (MMTT) at 24h or 3 months, followed by harvesting pancreas for histopathology and immunostaining. RESULTS: Cerulein-injected ferrets exhibited mild pancreatic edema, neutrophil infiltration, and elevations in serum amylase, lipase, TNF-alpha, IL-6, consistent with AP. Plasma glucose was significantly higher in ferrets with AP at all time points. Plasma glucagon, GLP-1 and PP were significantly higher in cerulein-injected animals, while plasma insulin was significantly lower compared to controls. OGTT and MMTT showed abnormal glycemic responses with higher area under the curve. The hypoglycemic response to insulin injection was completely lost, suggestive of insulin resistance. OGTT showed low plasma insulin; MMTT confirmed low insulin and GIP; abnormal OGTT and MMTT responses returned to normal 3 months after cerulein injection. CONCLUSIONS: Acute cerulein injection causes mild acute pancreatitis in ferrets and hyperglycemia related to transient islet cell dysfunction and insulin resistance. The ferret cerulein model may contribute to the understanding of hyperglycemia in acute pancreatitis. CI - Copyright (c) 2021 IAP and EPC. Published by Elsevier B.V. All rights reserved. FAU - Yi, Yaling AU - Yi Y AD - Department of Anatomy and Cell Biology, Iowa City, IA, USA. FAU - Sun, Xingshen AU - Sun X AD - Department of Anatomy and Cell Biology, Iowa City, IA, USA. FAU - Liang, Bo AU - Liang B AD - Department of Anatomy and Cell Biology, Iowa City, IA, USA. FAU - He, Nan AU - He N AD - Department of Anatomy and Cell Biology, Iowa City, IA, USA. FAU - Gibson-Corley, Katherine N AU - Gibson-Corley KN AD - Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA. FAU - Norris, Andrew W AU - Norris AW AD - Fraternal Order of Eagles Diabetes Research Center, Iowa City, IA, USA; Department of Pediatrics, lowa City, IA, USA; Department of Biochemistry, Iowa City, IA, USA. FAU - Engelhardt, John F AU - Engelhardt JF AD - Department of Anatomy and Cell Biology, Iowa City, IA, USA; Fraternal Order of Eagles Diabetes Research Center, Iowa City, IA, USA. FAU - Uc, Aliye AU - Uc A AD - Fraternal Order of Eagles Diabetes Research Center, Iowa City, IA, USA; Department of Pediatrics, lowa City, IA, USA; Department of Radiation Oncology; University of Iowa, Iowa City, IA, USA. Electronic address: aliye-uc@uiowa.edu. LA - eng GR - R01 DK115791/DK/NIDDK NIH HHS/United States GR - R01 DK118752/DK/NIDDK NIH HHS/United States GR - 27307C0010/ES/NIEHS NIH HHS/United States GR - RC2 DK124207/DK/NIDDK NIH HHS/United States GR - P30 DK054759/DK/NIDDK NIH HHS/United States GR - U01 DK108334/DK/NIDDK NIH HHS/United States PT - Journal Article DEP - 20210511 PL - Switzerland TA - Pancreatology JT - Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] JID - 100966936 RN - 0 (Blood Glucose) RN - 0 (Insulin) RN - 0 (Interleukin-6) RN - 0 (Tumor Necrosis Factor-alpha) RN - 59392-49-3 (Gastric Inhibitory Polypeptide) RN - 888Y08971B (Ceruletide) RN - 89750-14-1 (Glucagon-Like Peptide 1) RN - 9007-92-5 (Glucagon) RN - EC 3.1.1.3 (Lipase) RN - EC 3.2.1.- (Amylases) SB - IM MH - Acute Disease MH - Amylases MH - Animals MH - Blood Glucose MH - Ceruletide/toxicity MH - Ferrets MH - Gastric Inhibitory Polypeptide MH - Glucagon MH - Glucagon-Like Peptide 1 MH - Humans MH - *Hyperglycemia MH - Insulin MH - *Insulin Resistance MH - Interleukin-6 MH - Lipase MH - *Pancreatitis/chemically induced/veterinary MH - Tumor Necrosis Factor-alpha PMC - PMC8355067 MID - NIHMS1704920 OTO - NOTNLM OT - Glucagon OT - Glucose intolerance OT - Incretins OT - Insulin OT - Pancreatitis COIS- Declaration of competing interest Dr. Aliye Uc is an Associate Editor of Pancreatology, Subboard Chair of American Board of Pediatrics and Consultant for Cystic Fibrosis Foundation. All others authors declare no conflict of interests. EDAT- 2021/05/18 06:00 MHDA- 2022/01/06 06:00 PMCR- 2022/08/01 CRDT- 2021/05/17 05:42 PHST- 2021/01/13 00:00 [received] PHST- 2021/04/22 00:00 [revised] PHST- 2021/04/24 00:00 [accepted] PHST- 2021/05/18 06:00 [pubmed] PHST- 2022/01/06 06:00 [medline] PHST- 2021/05/17 05:42 [entrez] PHST- 2022/08/01 00:00 [pmc-release] AID - S1424-3903(21)00147-2 [pii] AID - 10.1016/j.pan.2021.04.008 [doi] PST - ppublish SO - Pancreatology. 2021 Aug;21(5):839-847. doi: 10.1016/j.pan.2021.04.008. Epub 2021 May 11.